Status:
UNKNOWN
Effects of Cardiac Sympathetic Blockade in Patients With Chronic Heart Failure
Lead Sponsor:
Harbin Medical University
Conditions:
Chronic Heart Failure
Eligibility:
All Genders
17-80 years
Brief Summary
Although current pharmaceutical therapies have improved the survival rate in heart failure it remains a fatal disease and is associated with a poor 3-year survival. Increased sympathetic activity foun...
Detailed Description
Although current pharmaceutical therapies have improved the survival rate in heart failure it remains a fatal disease and is associated with a poor 3-year survival. Increased sympathetic activity foun...
Eligibility Criteria
Inclusion
- chronic heart failure patients with the course of more than three months.
Exclusion
- Vavular heart diseases.
Key Trial Info
Start Date :
May 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT02282618
Start Date
May 1 2013
Last Update
November 4 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
the first affiliated hospital of Harbin Medical University
Harbin, Heilongjiang, China, 150001